Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04739670 |
| Title | Evaluating the Efficacy and Safety of Bevacizumab, Carboplatin, Gemcitabine and Atezolizumab in Breast Cancer (BELLA) |
| Acronym | BELLA |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Peter MacCallum Cancer Centre, Australia |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Royal North Shore | RECRUITING | St Leonards | New South Wales | 2065 | Australia | Details |
| Mater Health | RECRUITING | South Brisbane | Queensland | 4101 | Australia | Details |
| Monash Health | RECRUITING | Melbourne | Victoria | Australia | Details | |
| Peter MacCallum Cancer Centre | RECRUITING | Melbourne | Victoria | Australia | Details |